STSA Annual CFF
$8.74 M
-$64.54 M-88.07%
31 December 2022
Summary:
As of February 5, 2025, STSA annual cash flow from financing activities is $8.74 million, with the most recent change of -$64.54 million (-88.07%) on December 31, 2022. During the last 3 years, it has fallen by -$134.32 million (-93.89%).STSA Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
STSA Quarterly CFF
$0.00
-$17.00 K-100.00%
31 March 2023
Summary:
As of February 5, 2025, STSA quarterly cash flow from financing activities is $0.00, with the most recent change of -$17.00 thousand (-100.00%) on March 31, 2023. Over the past year, it has increased by +$500.00 thousand (+100.00%).STSA Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
STSA TTM CFF
$9.24 M
+$500.00 K+5.72%
31 March 2023
Summary:
As of February 5, 2025, STSA TTM cash flow from financing activities is $9.24 million, with the most recent change of +$500.00 thousand (+5.72%) on March 31, 2023. Over the past year, it has increased by +$11.18 million (+576.24%).STSA TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
STSA Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -88.1% | +100.0% | +576.2% |
| 3 y3 years | -93.9% | +100.0% | -93.5% |
| 5 y5 years | +100.0% | - | -93.5% |
STSA Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | -93.9% | -100.0% | -93.5% |
Satsuma Pharmaceuticals Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | $0.00(-100.0%) | $9.24 M(+5.7%) |
| Dec 2022 | $8.74 M(-88.1%) | $17.00 K(-99.8%) | $8.74 M(+5.5%) |
| Sept 2022 | - | $9.70 M(-2129.3%) | $8.28 M(-531.8%) |
| June 2022 | - | -$478.00 K(-4.4%) | -$1.92 M(-1.1%) |
| Mar 2022 | - | -$500.00 K(+13.6%) | -$1.94 M(-102.6%) |
| Dec 2021 | $73.28 M(-3588.0%) | -$440.00 K(-12.0%) | $73.28 M(+0.4%) |
| Sept 2021 | - | -$500.00 K(0.0%) | $72.99 M(-0.1%) |
| June 2021 | - | -$500.00 K(-100.7%) | $73.07 M(-0.1%) |
| Mar 2021 | - | $74.72 M(<-9900.0%) | $73.11 M(-3579.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | -$2.10 M(-101.5%) | -$733.00 K(+75.4%) | -$2.10 M(-142.0%) |
| Sept 2020 | - | -$418.00 K(-9.3%) | $5.00 M(-93.8%) |
| June 2020 | - | -$461.00 K(-5.7%) | $80.68 M(-43.4%) |
| Mar 2020 | - | -$489.00 K(-107.7%) | $142.52 M(-0.4%) |
| Dec 2019 | $143.06 M(+1208.9%) | $6.37 M(-91.5%) | $143.06 M(+4.7%) |
| Sept 2019 | - | $75.26 M(+22.6%) | $136.69 M(+122.5%) |
| June 2019 | - | $61.38 M(>+9900.0%) | $61.43 M(>+9900.0%) |
| Mar 2019 | - | $53.00 K | $53.00 K |
| Dec 2018 | $10.93 M(>+9900.0%) | - | - |
| Dec 2017 | $0.00 | - | - |
FAQ
- What is Satsuma Pharmaceuticals annual cash flow from financing activities?
- What is the all time high annual CFF for Satsuma Pharmaceuticals?
- What is Satsuma Pharmaceuticals annual CFF year-on-year change?
- What is Satsuma Pharmaceuticals quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Satsuma Pharmaceuticals?
- What is Satsuma Pharmaceuticals quarterly CFF year-on-year change?
- What is Satsuma Pharmaceuticals TTM cash flow from financing activities?
- What is the all time high TTM CFF for Satsuma Pharmaceuticals?
- What is Satsuma Pharmaceuticals TTM CFF year-on-year change?
What is Satsuma Pharmaceuticals annual cash flow from financing activities?
The current annual CFF of STSA is $8.74 M
What is the all time high annual CFF for Satsuma Pharmaceuticals?
Satsuma Pharmaceuticals all-time high annual cash flow from financing activities is $143.06 M
What is Satsuma Pharmaceuticals annual CFF year-on-year change?
Over the past year, STSA annual cash flow from financing activities has changed by -$64.54 M (-88.07%)
What is Satsuma Pharmaceuticals quarterly cash flow from financing activities?
The current quarterly CFF of STSA is $0.00
What is the all time high quarterly CFF for Satsuma Pharmaceuticals?
Satsuma Pharmaceuticals all-time high quarterly cash flow from financing activities is $75.26 M
What is Satsuma Pharmaceuticals quarterly CFF year-on-year change?
Over the past year, STSA quarterly cash flow from financing activities has changed by +$500.00 K (+100.00%)
What is Satsuma Pharmaceuticals TTM cash flow from financing activities?
The current TTM CFF of STSA is $9.24 M
What is the all time high TTM CFF for Satsuma Pharmaceuticals?
Satsuma Pharmaceuticals all-time high TTM cash flow from financing activities is $143.06 M
What is Satsuma Pharmaceuticals TTM CFF year-on-year change?
Over the past year, STSA TTM cash flow from financing activities has changed by +$11.18 M (+576.24%)